PERDIPINE Side Effects

6702306-X | Papuloerythroderma Of Ofuji
on Apr 27, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with renal hypertension and was treated with Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: papuloerythroderma of ofuji. Perdipine dosage: . During the same period patient was treated with EMABERIN (View Emaberin Review and Emaberin Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

6626026-5 | Papuloerythroderma Of Ofuji
Patient was taking Perdipine (View Usage). Patient had the following side effects: papuloerythroderma of ofuji on Mar 03, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with renal hypertension and. Perdipine dosage: . During the same period patient was treated with EMABERIN (View Emaberin Review and Emaberin Label ), FLUITRAN (View Fluitran Review and Fluitran Label ).

5743115-8 | Cerebral Haemorrhage
Adverse event was reported on Mar 27, 2008 by a Male patient taking Perdipine (View Usage) (Dosage: Unk) was diagnosed with hypertension, stomatitis, diarrhoea, abdominal pain upper, nausea (What is nausea?), constipation (What is constipation?), headache (What is headache?), prophylaxis and. Location: JAPAN , weighting 119.0 lb, After Perdipine was administered, patient had the following side effects: cerebral haemorrhage. During the same period patient was treated with DEXALTIN (Unk) (View Dexaltin Review and Dexaltin Label ), LOPEMIN (Unk) (View Lopemin Review and Lopemin Label ), OMEPRAZOLE (20 Mg) (View Omeprazole Review and Omeprazole Label ), SM (1 Df) (View Sm Review and Sm Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), GLYSENNID (Unk) (View Glysennid Review and Glysennid Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

5701593-4 | Cerebral Haemorrhage
on Mar 27, 2008 Male patient from JAPAN , weighting 119.0 lb, was diagnosed with hypertension, stomatitis, diarrhoea, abdominal pain upper, nausea (What is nausea?), constipation (What is constipation?), headache (What is headache?), prophylaxis and was treated with Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Perdipine dosage: Unk. During the same period patient was treated with DEXALTIN (Unk) (View Dexaltin Review and Dexaltin Label ), LOPEMIN (Unk) (View Lopemin Review and Lopemin Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), SM (1 Df) (View Sm Review and Sm Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), GLYSENNID (Unk) (View Glysennid Review and Glysennid Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.


5701592-2 | Cerebral Haemorrhage
on Mar 27, 2008 Male patient from JAPAN , weighting 119.0 lb, was diagnosed with hypertension, stomatitis, diarrhoea, abdominal pain upper, nausea (What is nausea?), constipation (What is constipation?), headache (What is headache?), prophylaxis and was treated with Perdipine (View Usage). Patient had the following side effects: cerebral haemorrhage. Perdipine dosage: Unk. During the same period patient was treated with DEXALTIN (Unk) (View Dexaltin Review and Dexaltin Label ), LOPEMIN (Unk) (View Lopemin Review and Lopemin Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), SM (1 Df) (View Sm Review and Sm Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), GLYSENNID (Unk) (View Glysennid Review and Glysennid Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

5642823-7 | Cerebral Haemorrhage
Patient was taking Perdipine (View Usage). After Perdipine was administered, patient had the following side effects: cerebral haemorrhage on Feb 18, 2008 from JAPAN Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with hypertension, stomatitis, diarrhoea, abdominal pain upper, nausea (What is nausea?), constipation (What is constipation?), headache (What is headache?), prophylaxis and. Perdipine dosage: . During the same period patient was treated with DEXALTIN (View Dexaltin Review and Dexaltin Label ), LOPEMIN (View Lopemin Review and Lopemin Label ), OMEPRAL (20 Mg) (View Omepral Review and Omepral Label ), SM (1.3 G) (View Sm Review and Sm Label ), MAGLAX (View Maglax Review and Maglax Label ), GLYSENNID (View Glysennid Review and Glysennid Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

5406928-8 | Stevens-johnson Syndrome
Adverse event was reported on Jul 23, 2007 by a Male patient taking Perdipine (View Usage) (Dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.) was diagnosed with hypertension, pyrexia, convulsion prophylaxis and. Location: JAPAN , 70 years of age, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), CERCINE (View Cercine Review and Cercine Label ), MYSLEE (View Myslee Review and Myslee Label ).

5406187-6 | Stevens-johnson Syndrome
on Jul 23, 2007 Male patient from JAPAN , 70 years of age, was diagnosed with hypertension, pyrexia, convulsion prophylaxis and was treated with Perdipine (View Usage). Patient had the following side effects: stevens-johnson syndrome. Perdipine dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.. During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), CERCINE (View Cercine Review and Cercine Label ), MYSLEE (View Myslee Review and Myslee Label ).

5401512-4 | Stevens-johnson Syndrome
on Jul 23, 2007 Male patient from JAPAN , 70 years of age, was diagnosed with hypertension, pyrexia, convulsion prophylaxis and was treated with Perdipine (View Usage). After Perdipine was administered, patient had the following side effects: stevens-johnson syndrome. Perdipine dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.. During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), CERCINE (View Cercine Review and Cercine Label ), MYSLEE (View Myslee Review and Myslee Label ).

5392301-8 | Stevens-johnson Syndrome
Patient was taking Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome on Jul 09, 2007 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with hypertension, pyrexia, convulsion prophylaxis and. Perdipine dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.. During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), CERCINE (View Cercine Review and Cercine Label ), MYSLEE (View Myslee Review and Myslee Label ).

5365588-5 | Abdominal Pain, Disseminated Intravascular Coagulation, Inflammatory Bowel Disease
Adverse event was reported on Jun 13, 2007 by a Male patient taking Perdipine (View Usage) (Dosage: Dose Reported As 96 Mg Continuous; 4 Ml/hour) was diagnosed with hypertension and. Location: JAPAN , 29 years of age, weighting 224.9 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), disseminated intravascular coagulation, inflammatory bowel disease. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ).

5338781-5 | Ileus Paralytic
on Jul 27, 2006 Male patient from JAPAN , 68 years of age, weighting 103.4 lb, was diagnosed with blood pressure management and was treated with Perdipine (View Usage). After Perdipine was administered, patient had the following side effects: ileus paralytic. Perdipine dosage: Duration:14 Hrs 55 Min: 24 July 2006, 1.35 P.m. 2.0 Ml/hr, 2:00 P.m. Increased To 3.0 Ml/hr, 5:00 P+. During the same period patient was treated with ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

5332291-7 | Abdominal Pain, Bacteraemia, Disseminated Intravascular Coagulation, Haemodialysis, Inflammatory Bowel Disease
on May 15, 2007 Male patient from JAPAN , 29 years of age, weighting 224.9 lb, was diagnosed with hypertension and was treated with Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bacteraemia, disseminated intravascular coagulation, haemodialysis, inflammatory bowel disease. Perdipine dosage: 120 Ml Daily. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ).

5288267-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Erythema Multiforme, Hepatic Function Abnormal, Purpura
Patient was taking Perdipine (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, erythema multiforme, hepatic function abnormal, purpura on Mar 27, 2007 from JAPAN Additional patient health information: Female patient , 64 years of age, weighting 136.7 lb, was diagnosed with hypertension, hypercholesterolaemia and. Perdipine dosage: . During the same period patient was treated with LIPITOR (Dosage Regimen Reported As 10 Mg, Uid/qd.) (View Lipitor Review and Lipitor Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), TOUGHMAC E (View Toughmac E Review and Toughmac E Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

5252965-6 | Erythema Multiforme, Hepatic Function Abnormal, Purpura
Adverse event was reported on Feb 19, 2007 by a Female patient taking Perdipine (View Usage) (Dosage: ) was diagnosed with hypertension, hypercholesterolaemia and. Location: JAPAN , 64 years of age, weighting 136.7 lb, After Perdipine was administered, patient had the following side effects: erythema multiforme, hepatic function abnormal, purpura. During the same period patient was treated with LIPITOR (Dosage Regimen Reported As 10 Mg, Uid/qd.) (View Lipitor Review and Lipitor Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), TOUGHMAC E (View Toughmac E Review and Toughmac E Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

5235240-5 | Cerebral Decompression, Depressed Level Of Consciousness, Headache, Hemiplegia, Intra-cerebral Aneurysm Operation, Respiratory Disorder, Subarachnoid Haemorrhage, Ventriculo-peritoneal Shunt
on Jan 30, 2007 Female patient from JAPAN , 56 years of age, was diagnosed with hypertension, hyperthyroidism, hypercholesterolaemia and was treated with Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral decompression, depressed level of consciousness, headache (What is headache?), hemiplegia, intra-cerebral aneurysm operation, respiratory disorder, subarachnoid haemorrhage, ventriculo-peritoneal shunt. Perdipine dosage: 40 Mg, Unk. During the same period patient was treated with THYRADIN S (View Thyradin S Review and Thyradin S Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), DIOVAN (40 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized and became disabled.

5217055-7 | Erythema Multiforme, Purpura
on Jan 15, 2007 Female patient from JAPAN , 64 years of age, was diagnosed with hypertension and was treated with Perdipine (View Usage). Patient had the following side effects: erythema multiforme, purpura. Perdipine dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), TOUGHMAC E (View Toughmac E Review and Toughmac E Label ). Patient was hospitalized.

5142014-2 | Cerebral Haemorrhage, Surgery
Patient was taking Perdipine (View Usage). After Perdipine was administered, patient had the following side effects: cerebral haemorrhage, surgery (What is surgery?) on Oct 20, 2006 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with hypertension, hyperthyroidism, hypercholesterolaemia and. Perdipine dosage: 40 Mg, Unk. During the same period patient was treated with THYRADIN S (View Thyradin S Review and Thyradin S Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), DIOVAN (40 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5096181-X | Haemodialysis, Renal Impairment
Adverse event was reported on Aug 02, 2006 by a Male patient taking Perdipine (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 66 years of age, Patient experienced the following unwanted or unexpected effects: haemodialysis, renal impairment. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), TAKEPRON (Orodispersable Tablet) (View Takepron Review and Takepron Label ), ATELEC (View Atelec Review and Atelec Label ). Patient was hospitalized.

4971012-4 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Bile Duct Obstruction, Bile Duct Stone, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Cholelithiasis
on Nov 14, 2005 Female patient from JAPAN , 80 years of age, was diagnosed with hypertension and was treated with Perdipine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), bile duct obstruction, bile duct stone, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholelithiasis. Perdipine dosage: 10 Mg, Bid. During the same period patient was treated with DIOVAN (20 Mg/day) (View Diovan Review and Diovan Label ), FELODIPINE (Unk, Unk) (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

4950746-1 | Bile Duct Stone, Liver Disorder
on Nov 14, 2005 Female patient from JAPAN , 80 years of age, was diagnosed with hypertension and was treated with Perdipine (View Usage). After Perdipine was administered, patient had the following side effects: bile duct stone, liver disorder. Perdipine dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

4944693-9 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Bile Duct Obstruction, Bile Duct Stone, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Cholelithiasis
Patient was taking Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), bile duct obstruction, bile duct stone, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cholelithiasis on Nov 14, 2005 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with hypertension and. Perdipine dosage: 10 Mg, Bid. During the same period patient was treated with DIOVAN (20 Mg/day) (View Diovan Review and Diovan Label ), FELODIPINE (Unk, Unk) (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

4910915-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Bile Duct Stone, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Inadequately Controlled, Cholelithiasis, Liver Disorder
Adverse event was reported on Nov 14, 2005 by a Female patient taking Perdipine (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 80 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), bile duct stone, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure inadequately controlled, cholelithiasis, liver disorder. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

4909824-5 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Back Pain, Bile Duct Obstruction, Bile Duct Stone, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Inadequately Controlled
on Nov 14, 2005 Female patient from JAPAN , 80 years of age, was diagnosed with hypertension and was treated with Perdipine (View Usage). After Perdipine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, back pain (What is back pain?), bile duct obstruction, bile duct stone, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure inadequately controlled. Perdipine dosage: 20 Mg, Bid. During the same period patient was treated with DIOVAN (20 Mg/day) (View Diovan Review and Diovan Label ), FELODIPINE (Unk, Unk) (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

4892625-4 | Hyperkalaemia, White Blood Cell Count Increased
on Jun 20, 2005 Female patient from JAPAN , 69 years of age, was diagnosed with hypertension, myasthenia gravis and was treated with Perdipine (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, white blood cell count increased. Perdipine dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.